MRM

TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January–March 2026). It also highlights trends over the past five quarters (2025Q1–2026Q1) to provide investors with a broader perspective. Data includes salons with comparable financial and customer metrics. 1. Salon Operation Business In 2026Q1, our salon business recorded an Average Revenue Per Customer of 7,822 JPY (+7.7% YoY), exceeding the Japanese industry average of 4,806 JPY by approximately 3,016 JPY.(*1) This performance reflects the strength of our service offering, supported by our training infrastructure and an educational curriculum refined over 25 years. Over 120 diverse training courses(Technical skills, Hospitality, Knowledge, Management)Continuous training system even after therapist debut Strategy Update: Hybrid Staffing Model In addition, to support sustainable growth in our store operations and further enhance service quality, we have been strategically upgrading the working styles of our store staff (therapists) since 2025. In addition to traditional employment models centered on hourly wages and fixed salaries, we have been promoting the adoption and expansion of a professional contractor (independent contractor) model. Key Performance Indicators (KPIs) *(1) Industry Average: Weighted average calculated based on data published by Recruit Co., Ltd., Hot Pepper Beauty Academy, “Beauty Census 2024 First Half (Relaxation Salon Edition) Report.”*(2) Number of Salons: Total number of directly operated and franchise salons at the end of each quarter.*(3) Total Customers: Number of customers visiting the salons.*(4) Revenue Per Customer: Average revenue calculated by dividing total sales by the number of customers.*(5) Repeat Ratio: Ratio of repeat customers to total customers.*(6) Operating Ratio: Ratio of treatment time to total working hours of therapists (excluding break times). The average number of stores included in the data aggregation for each quarter was 284 in 25Q1, 281 in 25Q2, 276 in 25Q3, 273 in 25Q4, and 268 in 26Q1. As a result of advancing both the transition to contractor agreements and the hiring of independent contractors, the proportion of independent contractors among therapists reached 45.1% as of Q1 2026, an increase from 29.8% in the same period of th...

Total Revenue: Increased by 21.5% to JPY52.7 million. Cost of Revenue Ratio: Decreased from 77% in 2023 to 72.9% in 2024. SG&A Expenses: Increased by 14.3%. Net Income: Increased by 20.1% to JPY0.9 million. Cash Flow from Operating Activities: JPY8.5 million. Cash Flow from Investing Activities: JPY2.3 million. Cash Flow from Financing Activities: JPY7.6 million. Adjusted EBITDA: Improved to JPY2.7 million. Adjusted EBITDA Margin: Improved to 5%. Net Cash and Cash Equivalents: Increased by JPY1.4 million. Average Revenue per Customer: Grew by 3.9%. Number of Salon Locations: Increased to 60 from 38 in the previous year. Warning! GuruFocus has detected 7 Warning Signs with MRM. Release Date: May 21, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Total revenue increased by 21.5% due to higher sales of salons and outsourcing revenues. Net income rose by 20.1%, driven by gains from sales of loans and tax asset valuation allowances. Adjusted EBITDA improved to JPY2.7 million with a margin increase to 5%. Average revenue per customer grew by 3.9%, indicating enhanced customer engagement. Expansion in the digital preventive healthcare segment with the upgraded LAB application and Mother bracelet. Cost of revenue increased by 15.1% due to salon purchase-back transactions. SG&A expenses rose by 14.3%, attributed to higher professional fees and recruiting expenses. Impairment loss recorded due to expected salon closures in 2025. Increased reliance on short-term and long-term bank loans for financing activities. Potential risks associated with global expansion and franchising plans. Q: Can you provide an overview of Medirom's financial performance in 2024? A: Fumitoshi Fujiwara, Chief Financial Officer, reported that total revenue increased by 21.5% to JPY52.7 million, driven by increased sales of salons and store operations outsourcing revenues. The cost of revenue ratio decreased from 77% in 2023 to 72.9% in 2024. Net income rose by 20.1% to JPY0.9 million, primarily due to gains from sales of loans and tax asset valuation allowances. Q: What were the key drivers of cash flow in 2024? A: Cash flow from operating activities was JPY8.5 million, mainly due to decreased accrued expenses and reclassification of PCs. Cash flow from investing activities was JPY2.3 million, attributed to proceeds from salon sales. Ca...

TOKYO, May 20, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”), today announced that for the year ended December 31, 2024, the Company had total revenue of $52,736,000, a 22% increase over total revenue of $43,388,000 for the year ended December 31, 2023. (The Company reports its financial results in Japanese yen and figures presented in this press release in US dollars have been translated for convenience at the exchange rate of ¥ 157.37 = US$1.00. See “Convenience Translations to US Dollars” below for more information.) Net income for 2024 was $878,000, or $0.17 per basic share, a 20% improvement compared with net income of $731,000, or $0.15 per basic share, for 2023. MEDIROM’s improvement in revenue in 2024 was primarily driven by a 23% increase in the Company’s Relaxation Salon Segment revenue to $47,317,000, compared with $38,507,000 in 2023. The Company’s increase in net income in 2024 was primarily the result of the rise in total revenue, a decrease in cost of revenues as a percentage of total revenues to 72.9% in 2024 compared with 77.0% during 2023, and a decrease in selling, general and administrative expenses as a percentage of total revenues to 27.0% in 2024 compared with 28.7% in 2023. As of December 31, 2024, MEDIROM had cash and cash equivalents of $2,093,000, compared with $676,000 as of December 31, 2023. The Company’s total indebtedness was $11,925,000 and $9,857,000 as of December 31, 2024 and 2023, respectively. Net cash used in operating activities was $8,462,000 in 2024 compared with $4,014,000 in 2023. Net cash provided in investing activities was $2,296,000 in 2024 while the Company had net cash used in investing activities of $2,088,000 in 2023. Net cash provided by financing activities was $7,583,000 in 2024 compared with $2,931,000 in 2023. Basic weighted average common shares outstanding were 5,107,404 in 2024 and 4,882,500 in 2023. “Thus far in 2025, MEDIROM has announced several notable developments,” said Chief Executive Officer Koji Eguchi. “In January, the Company’s subsidiary, MEDIROM MOTHER Labs Inc., began providing its remote health monitoring system, REMONY, and charging-free smart tracker device, MOTHER Bracelet®︎, to the Electronics Division of TOPPAN Inc. Also in January, all corporate capital registration proced...

TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company filed its most recent annual report on Form 20-F, which annual report covers the Company’s financial results for the 2024 fiscal year and is available on the Securities and Exchange Commission website at www.sec.gov. To access the webcast, please go to the following URL five to ten minutes prior to its start: https://event.choruscall.com/mediaframe/webcast.html?webcastid=9rHZ3uFf To participate in the webcast, please use the following dial-in numbers: Conference Replay: A replay of this call will be available on May 21, 2025 at 11:30 a.m. ET until June 4, 2025, at 11:59 PM ET. To access the replay, please dial: To access the replay using an international dial-in number, please select the following link: https://services.choruscall.com/ccforms/replay.html About MEDIROM Healthcare Technologies Inc. MEDIROM, a holistic healthcare company, operates 307 (as of March 31, 2025) relaxation salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en. Forward-Looking Statements Certain statements in this press release are forward-looking statements for purposes of the safe har...